July 26 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* GROUP IS EXPECTED TO RECORD A DECREASE IN REVENUE FOR SIX
MONTHS
ENDED 30 JUNE 2019
* EXPECTED TO RECORD A DECREASE IN PROFIT BEFORE LISTING
EXPENSES
FOR SIX MONTHS ENDED 30 JUNE 2019
* EXPECTED RESULT DUE TO DECREASE IN SALES TO SOME OF
CUSTOMERS OF
GROUP
* EXPECTED RESULT DUE TO DECREASE IN SALES TO SOME OF
CUSTOMERS OF
GROUP, INCLUDING DIRECT SALES CUSTOMERS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8j9073
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))